Living Related Donor Liver Transplantation in Children

Carregando...
Imagem de Miniatura
Citações na Scopus
37
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Citação
TRANSPLANTATION PROCEEDINGS, v.43, n.1, p.161-164, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective. The objective of this study was to report our experience with pediatric orthotopic liver transplantation (OLT) with living related donors. Methods. We performed a retrospective chart analysis of 121 living related donor liver transplantations (LRDLT) from June 1998 to June 2010. Results. Indications were biliary atresia (BA; n = 81), primary sclerosing cholangitis (n = 5), alpha-1 antitrypsin deficiency (n = 4); cholestasis (n = 9), fulminant hepatic failure (n = 8), autoimmune hepatitis (n = 2), Alagille syndrome (n = 4), hepatoblastoma (n = 3), tyrosinemia (n = 2), and congenital hepatic fibrosis (n = 3). The age of the recipients ranged from 7-174 months (median, 22) and the weights ranged from 6-58 kg (median, 10). Forty-nine children (40.5%) weighed <= 10 kg. The grafts included the left lateral segment (n = 108), the left lobe (n = 12), and the right lobe (n = 1). The donors included 71 mothers, 45 fathers, 2 uncles, 1 grandmother, 1 grandfather, and 1 sister with a median age of 29 years (range, 16-53 ys) and a median weight of 68 kg (range, 47-106). Sixteen patients (12.9%) required retransplantation, most commonly due to hepatic artery thrombosis (HAT; n = 13; 10.7%). The other complications were biliary stenosis (n = 25; 20.6%), portal vein thrombosis (PVT; n = 11; 9.1%), portal vein stenosis (n = 5; 4.1%), hepatic vein stenosis (n = 6; 4.9%), and lymphoproliferative disorders (n = 8; 6.6%). The ultimate survival rate of recipients was 90.3% after 1 year and 75.8% after 3 years. Causes of early death within 1 month were HAT (n = 6), PVT (n = 2), severe graft dysfunction (n = 1), sepsis (n = 1), and intraoperative death in children with acute liver failure (n = 2). Causes of late deaths included lymphoproliferative disease (n = 3), chronic rejection (n = 2), biliary complications (n = 3), and recurrent disease (n = 3; hepatoblastoma and primary sclerosing cholangitis). Conclusions. Despite the heightened possibility of complications (mainly vascular), LRDLT represented a good alternative to transplantation from cadaveric donors in pediatric populations. It was associated with a high survival ratio.
Palavras-chave
Referências
  1. Otte JB, 2003, TRANSPLANTATION, V75, P1625, DOI 10.1097/01.TP.0000065020.55959.4A
  2. Pastacaldi S, 2001, LIVER TRANSPLANT, V7, P75, DOI 10.1053/jlts.2001.22040
  3. Marcos A, 2000, ANN SURG, V231, P824, DOI 10.1097/00000658-200006000-00006
  4. Wojcicki M, 2008, DIGEST SURG, V25, P245, DOI 10.1159/000144653
  5. Sieders E, 2000, TRANSPLANTATION, V70, P1448, DOI 10.1097/00007890-200011270-00009
  6. Bahador A, 2009, TRANSPL P, V41, P2864, DOI 10.1016/j.transproceed.2009.07.046
  7. Gibelli NEM, 2009, TRANSPL P, V41, P955, DOI 10.1016/j.transproceed.2009.01.055
  8. Heaton N, 2008, BRIT J SURG, V95, P919, DOI 10.1002/bjs.6060
  9. Kawachi S, 2002, SURGERY, V132, P48, DOI 10.1067/msy.2002.125314
  10. KOBORI L, 2008, ORVOSI HETILAP, V149, P127
  11. Matsuda H, 2006, SURG TODAY, V36, P245, DOI 10.1007/s00595-005-3131-3
  12. Otte JB, 2004, PEDIATR TRANSPLANT, V8, P317, DOI 10.1111/j.1399-3046.2004.00205.x
  13. POMPOSELLI JJ, 2006, TRANSPLANTATION S2, V82, P705
  14. RASMUSSEN A, 1994, TRANSPLANT P, V26, P1792
  15. Takahashi Y, 2009, PEDIATR SURG INT, V25, P745, DOI 10.1007/s00383-009-2430-y
  16. Wamaar N, 2010, LIVER TRANSPLANT, V16, P847
  17. Yang Y, 2010, WORLD J GASTROENTERO, V16, P2682, DOI 10.3748/wjg.v16.i21.2682